Tue, Aug 20 10:25am

Compare EYPT

EyePoint Pharmaceuticals, Inc. - Common Stock [EYPT]
$1.45 0.02 (1.37%)

EYPT Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 160 Million
EYPT Description

EyePoint Pharmaceuticals Inc is a US-based specialty pharmaceutical company which is engaged in developing sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The company has developed three sustained-release products for the treatment of back-of-the-eye diseases. The lead product candidate is Durasert which is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye for three years from a single injection. The company's development program is focused primarily on utilizing two core technology platforms to deliver drugs and biologics to treat chronic diseases.

Visit Website

EYPT Earnings

EPS -0.11 P/E Ratio 0.00
Previous Earnings Wed, May 8, 2019
Latest Earnings Wed, Aug 7, 2019 (13 days ago) +15.87%

EYPT Dividend

Yield --
Ex-Date --
Pay Date --
History --

EYPT Charts

1 Year
Aug 5, 2019
Oct 3, 2018

Symbol Price Day % YTD %
EYPT $1.45 -1.37% -25.64%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy